Language
Indonesia| Author | Title | Action |
|---|---|---|
| Kanika Dogar | Unmasking severe lepra reactions : clinical insights, predictive risk factors and treatment outcomes | View |
| Marco Andrey Cipriani Frade | Head-to-Head Comparison: RIMOXCLAMIN vs. Standard MDT in Hansen’s Disease Treatment | View |
| Dr Reeti Tewari Dass, and Tina Mendis | Children led community intervention for zero leprosy transmission: A learning from 3 different regions of India | View |
| Marco Andrey Cipriani Frade | Beyond the Pilot: RIMOXCLAMIN's Therapeutic Impact in a Larger Brazilian Hansen’s Disease Population - a comparative study | View |
| Philemon Das | Effective healthcare and socioeconomic support can help prevent worsening of disability due to leprosy | View |
| Marco Andrey Cipriani Frade | Efficiency of the Sensory Mapping Score for Hansen’s Disease Diagnosis and Follow-up: A Functional Cure Criterion? | View |
| Alex Frank Raulim | What Comes Next for OPLD Sustainability After Project Phase-out? | View |
| Prakhar Srivastava | Factors Affecting Outcomes in Cutaneous TB Treated with ATT at a Tertiary Care Hospital in India: A Retrospective Analysis | View |
| Deanna A. Hagge | An update on the immunological aspects of Erythema Nodosum Leprosum (ENL) | View |
| DAVID PRAKASH KUMAR M | The social and economic impact of foot ulcers in leprosy | View |
